Skip to main content
. 2020 Jan 7;12(1):51. doi: 10.3390/pharmaceutics12010051

Figure 3.

Figure 3

XRPD patterns of Cloisite, Eudragit RS, and their extruded nanocomposites. (A): (a) Cloisite Na; (b) 5% Cloisite Na–95% Eudragit RS physical mixture; (c) Eudragit RS; (d) nanocomposite containing 5% Cloisite Na; (e) nanocomposite containing 10% Cloisite Na; (f) nanocomposite containing 15% Cloisite Na. (B): (a) Cloisite 20; (b) 5% Cloisite 20%–95% Eudragit RS physical mixture; (c) Eudragit RS; (d) nanocomposite containing 5% Cloisite Na; (e) nanocomposite containing 10% Cloisite Na; (f) nanocomposite containing 15% Cloisite Na.